Woodline Partners »

Summit Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.4M 215k 20.66
2025-06-30 $3.9M 182k 21.28